Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.01
-0.15-2.91%
At close: -
$5.06
0.050.94%
After Hours: May 9, 7:52 PM EDT
Comments
Loading...
Xeris Biopharma Holdings Stock Price, Quotes and Forecasts
XERSNASDAQ
Xeris Biopharma Holdings (XERS) Forecast
NewsEarningsXeris Biopharma Holdings (XERS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Xeris Biopharma Holdings Stock Price, Quotes and Forecasts | NASDAQ:XERS | Benzinga
Explore Xeris Biopharma Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XERS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Xeris Biopharma Holdings (XERS) stock?
You can purchase shares of Xeris Biopharma Holdings (NASDAQ:XERS) through any online brokerage.
Who are Xeris Biopharma Holdings (XERS) competitors?
Other companies in Xeris Biopharma Holdings’s space includes: Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
What is the forecast, or price target, for Xeris Biopharma Holdings (XERS) stock?
Xeris Biopharma Holdings has a consensus price target of $5.88.
What is the current price for Xeris Biopharma Holdings (XERS)?
The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $5.057 last updated May 9, 2025 at 7:52 PM EDT.
Does Xeris Biopharma Holdings (XERS) pay a dividend?
There are no upcoming dividends for Xeris Biopharma Holdings.
When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?
Xeris Biopharma Holdings’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is Xeris Biopharma Holdings (XERS) going to split?
There is no upcoming split for Xeris Biopharma Holdings.
What sector and industry does Xeris Biopharma Holdings (XERS) operate in?
Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
